<DOC>
	<DOCNO>NCT01643551</DOCNO>
	<brief_summary>An observational study neuron specific enolase , marker reperfusion injury , LVAD recipients follow VAD implantation .</brief_summary>
	<brief_title>Neuron Specific Enolase Ventricular Assist Device Recipients</brief_title>
	<detailed_description>Patients eligible leave ventricular assist device ( LVAD ) typically severe heart failure , characterize poor cardiac output . The relatively abrupt increase cardiac output follow implant LVAD may cause reperfusion injury . Furthermore , select patient may particularly severe consequence injury , include refractory acidosis vasoplegia . Neuron specific enolase ( NSE ) establish biomarker reperfusion injury . We hypothesize change NSE follow LVAD great change NSE note control population patient undergo non-VAD cardiac surgery .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<criteria>Group 1 PreVAD implantation patient 18 year old lanning undergo VAD implantation Group 2 Cardiac Surgery Comparison Group 18 year old Planning undergo valve coronary bypass surgery Acute cerebrovascular infarction</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>Heart Failure</keyword>
	<keyword>Left Ventricular Assist Device</keyword>
	<keyword>Reperfusion Injury</keyword>
	<keyword>Neuron Specific Enolase</keyword>
</DOC>